L
iving well is as important to most people as living longer. Therefore, the concept of quality of life (QOL) has gained much attention in biomedical science over the past few decades (1, 2) . In this respect, comprehensive assessments of QOL and other patient-reported outcomes (PROs) have become indispensable (1) (2) (3) (4) .
PROs are descriptions coming directly from patients about how they feel or function in relation to their health and well-being (5),
and have been associated with important medical outcomes (6) . Although the cardiology community recognizes that it is imperative to assess PROs to better understand the impact of health and disease, these outcomes remain underused in cardiovascular clinical trials (7) . Moreover, many studies on PROs in the larger field of chronic diseases use poor-quality instruments (8) .
In the cardiac subspecialty of congenital heart disease (CHD), QOL research commenced 40 years ago and has increased exponentially over time (9) . To date, more than 230 QOL studies in CHD conducted in 35 countries have been published (9) . However, a critical appraisal revealed that most articles on QOL had substantial conceptual and methodological deficits (9), yielding inconsistent results (10, 11) . Such inconsistencies may be attributable to differences in methodological approaches or to genuine differences in QOL between patients living in different countries (12) . Furthermore, these studies investigated only demographic and/or medical predictors of QOL, leaving population measures or cultural dimensions unaddressed. It is reasonable to hypothesize that QOL scores among adults with CHD might be higher in countries known to have higher QOL in the general population (e.g., Denmark, Norway, or Switzerland). This possibility, however, has never been investigated.
To gain a better understanding of QOL in patients with CHD worldwide, it is critical to examine QOL in different countries using a uniform research methodology. This allows us to ascertain whether there are genuine differences in QOL in patients living in different countries, independent of methodological considerations. Furthermore, it enables us to evaluate whether country-specific characteristics explain QOL above and beyond patient characteristics. Therefore, the aims of this study were to: 1) describe QOL in a large international sample of adults with CHD; 2)
investigate the association between QOL and patient characteristics (i.e., sociodemographic and medical variables); and 3) explore variation in QOL across countries and investigate the relationship between QOL and country characteristics (i.e., general population happiness and cultural dimensions).
METHODS
We established an international collaborative research group and undertook APPROACH-IS instruments produced a more robust score than the use of other instruments (9) .
The LAS is a vertically oriented line that ranges from 0 (worst imaginable QOL) to 100 (best imaginable QOL) (15) . The LAS has well-established reliability and validity for adults with CHD (15) and it is used frequently in medical research (16, 17) .
The SWLS assesses a person's global judgment of life satisfaction and comprises 5 statements with a response scale ranging from 1 (strongly disagree) to 7 (strongly agree). A score of 20 represents the neutral point on the scale (18) . The SWLS has good psychometric properties (15, 19) .
PATIENT-AND COUNTRY-SPECIFIC CHARACTERISTICS.
Demographic data including sex, age, marital status, educational level, employment status, and patient-reported New York Heart Association (NYHA) functional class assessment were collected using a self-report questionnaire. The complexity of patients' heart defects (simple, moderate, or complex) was extracted from medical records (12) .
Country-specific data on happiness (i.e., a popu- Quality of Life in Adult Congenital Heart Disease 93.8%) were included in the GLMM. Data analysis was performed using SAS software, version 9.2 (SAS Institute Inc., Cary, North Carolina).
RESULTS
Overall, 4,028 adults with CHD were enrolled in the study. Characteristics of the total sample are detailed in In multivariable GLMM analyses, older age; job seeking, being unemployed, or disabled; never having been married; and higher NYHA functional classes were associated with worse QOL (p < 0.001) ( Table 2) . Apers et al.
A weak positive relationship between national happiness levels and QOL was suggested (Central Illustration). Univariable analyses showed that this relationship was not significant (p ¼ 0.0624) ( Table 3) . Quality of Life in Adult Congenital Heart Disease assessment) were more important contributory factors to QOL than defect complexity. On an international scale, these results confirmed earlier findings that QOL is related marginally to the severity of the heart defect (objective criterion) and more strongly correlated with illness perceptions and appraisal of functional status (subjective criteria) (14, 24, 25) . Therefore, patients with complex CHD might report a good QOL, particularly if they do not experience functional impediments or symptoms on a day-to-day basis (26) .
Findings from our study demonstrated that QOL in adults with CHD varied across countries. This international variation in QOL remained after adjustment for patient-and country-specific characteristics.
Although a few points separated most countries, a Abbreviations as in Table 1 .
Apers et al. In this study, quality of life (QOL) in adults with congenital heart disease was estimated using empirical Bayes estimates derived from the general linear mixed model without adjusting for patient and country-specific characteristics and are based on the linear analog scale for QOL. When compared with the national happiness levels based on the World Happiness Report 2013, a weak positive relationship was suggested between the 2, although the relationship was not statistically significant. *Results from GLMMs with country-specific characteristics as additional QOL predictors (LAS) in adults with congenital heart disease (n ¼ 3,777). †The multivariable model also contains all patient characteristics included in Table 2 as predictors, but results are reported only for country-specific characteristics. Total explained variability derived from the chi-square statistic: 21.6%; random country effect: chi-square ¼ 63.9 (p < 0.001); explained variability by country derived from the chi-square statistic: 1.7%. ‡Based on the World Happiness Report 2013. §Based on dimensions of national culture by Hofstede. kp value based on chi-square statistic (likelihood-ratio test with 6 degrees of freedom) to test any effect of the 6 cultural dimensions. Results based on the LAS for QOL. Tables 1 and 2 . Furthermore, the care of adult CHD patients is an issue only in some African countries. Fifth, we were not able to verify differential item functioning in this study.
Abbreviations as in
Differential item functioning means that people from different groups (e.g., North American vs. Asian patients) have a different probability of giving a certain response on a questionnaire. Differential item functioning should be an area of scrutiny in future analyses of international PRO data.
In conclusion, this is the first large-scale international study comprehensively assessing QOL in patients with CHD. Overall QOL in adults with CHD was found to be generally good and QOL varied across countries. This between-country variation was related to some patient characteristics, including age, marital status, employment status, and patientreported NYHA functional class assessment.
Country-specific characteristics, including national happiness level and cultural dimensions, were not responsible for variation in QOL.
